Figure 2From: Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 studyOverall survival (in months) of patients with mobility problems (as coded 2–3) (dotted line; n = 54) and patients without mobility problems (as coded 1) (solid line; n = 223). Log-rank p value = 0.0011. The median survival times were 20.9 (95% CI = [18.6–24.9]) months and 11.8 (95% CI = [11.1–17.3]) months for patients without problems (coded as 1) and those with problems (as coded 2–3), respectively.Back to article page